Mutant EK1 with Q1004E/N1006I: a promising fusion inhibitor for the HR1 domain of SARS-CoV-2. Yan F, Gao F. J Infect 2021 Dec 22. pii: S0163-4453(21)00644.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yan F, Gao F. Mutant EK1 with Q1004E/N1006I: a promising fusion inhibitor for the HR1 domain of SARS-CoV-2. J Infect 2021 Dec 22. pii: S0163-4453(21)00644.
PMID: 34953899